Advanced three‐dimensional in vitro liver models to study the activity of anticancer drugs

Agnieszka Zuchowska,Sonia Frojdenfal,Maciej Trzaskowski,Elzbieta Jastrzebska
DOI: https://doi.org/10.1002/biot.202400159
2024-06-20
Biotechnology Journal
Abstract:Graphical and Lay Summary 3D liver aggregates formed with three main liver cell types such a hepatocytes, hepatic stellate cells and hepatic sinusoidal endothelial cells psented in vivo liver features and high drug metabolic properties. The liver is one of the most important organs in the human body. It performs many important functions, including being responsible for the metabolism of most drugs, which is often associated with its drug‐induced damage. Currently, there are no ideal pharmacological models that would allow the evaluation of the effect of newly tested drugs on the liver in preclinical studies. Moreover, the influence of hepatic metabolism on the effectiveness of the tested drugs is rarely evaluated. Therefore, in this work we present an advanced model of the liver, which reflects most of the morphologically and metabolically important features of the liver in vivo, namely: three‐dimensionality, cellular composition, presence of extracellular matrix, distribution of individual cell types in the structure of the liver model, high urea and albumin synthesis efficiency, high cytochrome p450 activity. In addition, the work, based on the example of commonly used anticancer drugs, shows how important it is to take into account hepatic metabolism in the effective assessment of their impact on the target organ, in this case cancer. In our research, we have shown that the most similar to liver in vivo are 3D cellular aggregates composed of three important liver cells, namely hepatocytes (HepG2), hepatic stellate cells (HSCs), and hepatic sinusoidal endothelial cells (HSECs). Moreover, we showed that the cells in 3D aggregate structure need time (cell–cell interactions) to improve proper liver characteristic. The triculture model additionally showed the greatest ability to metabolize selected anticancer drugs.
biotechnology & applied microbiology,biochemical research methods
What problem does this paper attempt to address?